Analysts Stocks

      Morgan Stanley cuts DOCS target to $35, stays Overweight

      Ricky Goldwasser at Morgan Stanley lowered their price target on DOCS to $35 on May 14, keeping the rating at Overweight.

      Ricky has made 18 price-target calls on DOCS that AnaChart has tracked. 15 of 18 were touched by the stock’s price at some point after the call.

      DOCS carries 14 Buy, 5 Hold ratings among the analysts AnaChart tracks. Needham‘s Scott Berg holds the high end of the range at $67; Wells Fargo‘s Stan Berenshteyn anchors the low end at $18. The stock’s most recent close was $22.01.

      DOCS price target chart: Morgan Stanley cuts to $35
      Ricky Goldwasser’s DOCS target history against the street high, street low and the stock price. Each dot marks a dated call.

      The $35 target is 59% above the stock’s $22.01 close.

      FAQ

      What is Morgan Stanley’s price target on DOCS?

      Morgan Stanley’s Ricky Goldwasser has a $35 target on DOCS, rated Overweight, set May 14, 2026.

      How often have Ricky Goldwasser’s DOCS price targets been reached?

      AnaChart has tracked 18 price-target calls from Ricky Goldwasser on DOCS; the stock reached the target in 15 of them (83%).

      What is the analyst view on DOCS?

      Coverage is split 14 Buy / 5 Hold / 0 Sell, with targets from $18 (Wells Fargo) to $67 (Needham).